Taxa Biotechnologies, Inc. Launches Title III Regulation CF Equity Crowdfunding Campaign

Press Release – SAN FRANCISCO — May 16th, 2016 — TAXA Biotechnologies, Inc (TAXA) today announced it is making a Regulation CF equity crowdfunding offering on WeFunder.com thanks to the SEC Regulation Crowdfunding (CF) that permits public offerings of securities to be made without registration with the SEC under Section 4(a)(6) of the Securities Act of 1933, which was added to the securities laws by Title III of the Jumpstart Our Business Startups (JOBS) Act. The company will be offering up to $1 Million at a $1 share price with a $7 million valuation cap.

TAXA Biotechnologies was founded in 2013 and has its principal office in San Francisco, California. TAXA Biotechnologies is a company of biologists and experts who use synthetic biology technologies to engineer new organisms which can be nurtured at home as carbon-positive alternatives to existing products.

The first biotech investment by Y Combinator, TAXA Biotechnologies provides access to a platform for protein engineering, automated DNA assembly, transient experiments and stable transformation as a service that is already being used by three partners.

Interested individuals can visit www.taxa.com/invest for more information on the company and its Regulation CF Title III offering.

The post Taxa Biotechnologies, Inc. Launches Title III Regulation CF Equity Crowdfunding Campaign appeared first on GoodCrowd.info.